Abstract 15999: Proportional Pulse Pressure and Shock Index as Predictors of Cardiac Index in Patients With Intermediate-Risk Pulmonary Embolism

Abstract

Background: Risk stratification in intermediate-risk pulmonary embolism (PE) plays an important role in appropriate selection of therapies, however this is often challenging given variable phenotype. Proportional pulse pressure (PPP) and shock index (SI) have demonstrated to accurately predict cardiac index (CI) in patients with cardiogenic shock. Nonetheless, their applicability to patients with acute PE remains uncertain. Our objective is to investigate whether PPP and SI correlate with invasive assessment of CI in intermediate-risk PE. Methods: We retrospectively analyzed patients included in the Pulmonary Embolism Response Team (PERT) registry at NYCH+H/Bellevue who underwent invasive hemodynamic assessment. PPP was calculated as systolic blood pressure - diastolic blood pressure/systolic blood pressure. SI was calculated as heart rate/systolic blood pressure. Linear regression and correlation coefficients were used to examine the relationship between PPP, SI and CI as well as other clinical variables. Results: A total of 45 intermediate-risk PE patients were included (mean age was 57 ± 13 years and 43% were female). The SI moderately correlated with the composite pulmonary embolism shock score (CPES) (r = 0.5, p=0.0002), sPESI (r = 0.37, p=0.007), cardiac index (-0.42, p=0.004) and poorly correlated with lactate levels (r=0.23, p=0.18). PPP correlated poorly with CPES (r = 0.01, p=0.96), sPESI (r = -0.04, p=0.73), CI (r = 0.1 p=0.51) and lactate (-0.18, p=0.2). There was poor correlation between SI and PPP (r = -0.17, p=0.23). For every 0.1 increase in the shock index, the cardiac index was lower by 0.17L/minute/m 2 (p=0.017). Conclusions: In patients with intermediate-risk PE, a higher SI was associated with a lower CI, while PPP was not associated with CI. SI may provide additional valuable information to risk-stratify patients with acute PE and can potentially assist clinicians in triaging monitoring level therapeutic decisions.